Sales rise 10.10% to Rs 857.20 crore
Net profit of Glaxosmithkline Pharmaceuticals reported to Rs 156.51 crore in the quarter ended December 2020 as against net loss of Rs 661.16 crore during the previous quarter ended December 2019. Sales rose 10.10% to Rs 857.20 crore in the quarter ended December 2020 as against Rs 778.59 crore during the previous quarter ended December 2019. ParticularsQuarter EndedDec. 2020Dec. 2019% Var.Sales857.20778.59 10 OPM %23.9715.98 -PBDT218.59137.91 59 PBT200.88119.58 68 NP156.51-661.16 LPPowered by Capital Market - Live News